Haleon plc
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain r…
Drug Manufacturers - Specialty & Generic
GB, Weybridge [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Haleon plc (HLNCF) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Manufacturers—Specialty & Generic Average | - - | - - | - - | 234,837.45 | 40,214.16 | 1,633.02 | 60,206.78 | -450.84 | 0.01 | 43.5041 | 84.03 | 0.4336 | -0.3735 | 0.00 | 0.01 | 2.4302 | - - | ||
| Maximum | - - | - - | - - | 8,626,028.00 | 528,312.00 | 32,061.00 | 1,988,352.00 | 16,134.00 | 0.08 | 2,279.6263 | 3,215.80 | 1.0000 | 1.6542 | 0.13 | 1.46 | 35.1990 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 0.00 | -15,489.00 | -277,041.00 | -30,106.00 | 0.00 | -1,306.5021 | -853.08 | -3.9254 | -42.3731 | -0.31 | -0.90 | 0.0000 | - - | ||
| Viatris Inc. VTRS | 13.37 | 0.24 1.83% | 7,467 vs. 7,669 | 15,958.00 | 3,656.00 | 113.00 | 563.00 | 4,607.00 | 0.0953 | 31.3228 | 0.0100 | 0.4157 | 0.0311 | 0.0057 | 0.0024 | 0.6507 | 1,193.00 | ||
| Haleon plc HLNCF | 4.56 | 0.08 1.79% | 1 vs. 52 | 41,283.00 | 2,919.00 | 423.00 | 0.00 | 0.00 | 0.0460 | 18.0545 | 0.0000 | 0.6297 | 0.1449 | 0.0253 | 0.0000 | 0.0000 | 9,053.00 | ||
| Zoetis Inc. ZTS | 176.96 | 0.25 0.14% | 1,503 vs. 2,094 | 79,838.00 | 2,190.00 | 599.00 | 455.00 | 10,696.00 | 1.3100 | 31.9262 | 0.0026 | 0.6895 | 0.2735 | 0.1184 | 0.0417 | 1.7119 | 451.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.